CD34 and peripheral arterial disease: In contrast to the total CD34+ cell population, in non-diabetic patients with MVD (PAD or CAD), the CD34+KDR+ progenitor cell subset was reduced to the same extent (1.7-fold reduction) as observed in diabetes when compared with healthy controls (Fig. 1g; p < 0.05).